000			01796 a2200529 4500
005			20250513032028.0
264		0	_c19951107
008			199511s 0 0 eng d
022			_a1120-6721
024	7		_a10.1177/112067219500500203 _2doi
040			_aNLM _beng _cNLM
100	1		_aAdenis, J P
245	0	0	_aCiprofloxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis. _h[electronic resource]
260			_bEuropean journal of ophthalmology _c
300			_a82-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Disease
650	0	4	_aAdministration, Topical
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBacteria _xdrug effects
650	0	4	_aBlepharitis _xdrug therapy
650	0	4	_aChild
650	0	4	_aChronic Disease
650	0	4	_aCiprofloxacin _xadverse effects
650	0	4	_aConjunctiva _xmicrobiology
650	0	4	_aConjunctivitis, Bacterial _xdrug therapy
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Tolerance
650	0	4	_aEye Infections, Bacterial _xdrug therapy
650	0	4	_aEyelids _xmicrobiology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOphthalmic Solutions
650	0	4	_aRifamycins _xadverse effects
650	0	4	_aTreatment Outcome
700	1		_aColin, J
700	1		_aVerin, P
700	1		_aSaint-Blancat, P
700	1		_aMalet, F
773	0		_tEuropean journal of ophthalmology _gvol. 5 _gno. 2 _gp. 82-7
856	4	0	_uhttps://doi.org/10.1177/112067219500500203 _zAvailable from publisher's website
999			_c7548901 _d7548901